Specialty Pharmaceutical Company dedicated to patients living with chronic conditions

SEC Filing Details

Home » Investors » Financials » SEC Filings » SEC Filing Details

« Back

Document Details

Form
PRE 14A
Filing Date
Jun 6, 2008
Document Date
Jul 24, 2008
Form Description
A preliminary proxy statement providing notification matters to be brought to a vote
Filing Group
Proxy Filings
Company
BioDelivery Sciences International, Inc.
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC

Investor Presentation

  • Corporate Governance

    • Get the latest details on our products and services.

    SIGN UP

    Top News

    BioDelivery Sciences Acquires U.S. Commercial Rights to Symproic®
    Thank you. We will get back to you soon